BioSpace News Archive

3 Biotechs That Got Huge Boosts From Spark's FDA P

Drug Development

Bristol-Myers’ Lung Cancer Opdivo Trial Stopped Early for Superior Overall Survival

Bristol-Myers Squibb has its eyes set on carving out a strong position in the lucrative Chinese lung cancer market.

November 30, 2017

·

2 min read

·

Alex Keown

Gemini Therapeutics Banks $42.5M to Bring Precisio

Biotech Bay

3 Big Pharmas That Could be Winners for Investors in the Long Run

Big pharma stocks have been longtime favorites among investors for several reasons.

November 30, 2017

·

1 min read

Biotech Bay

3 Bioeconomy Stocks Investors Should Not Hesitate to Buy

While the words biotech and biopharma are often used interchangeably, they aren’t the same thing - not even close, in fact.

November 30, 2017

·

1 min read

Drug Development

Higher Death Rate Forces Bayer to Stop Xofigo/Zytiga Combo Late-Stage Study Early

An IDMC told Bayer that it should unblind its Phase III clinical trial in prostate cancer in order to further analyze an increased number of fractures and deaths.

November 30, 2017

·

2 min read

·

Mark Terry

FDA

Foundation Medicine Wins Approval From the FDA and Medicare for First-of-Its-Kind Cancer Test

Foundation Medicine’s sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday.

November 30, 2017

·

2 min read

·

Alex Keown

Drug Development

Carrick Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of its Oral CDK7 Inhibitor: CT7001

Efficacy studies are planned to start in 2018.

November 30, 2017

·

3 min read

Orexo Publishes Prospectus and Applies for Listing of Bonds on Nasdaq Stockholm

The Company intends to list the bonds on the corporate bond list of Nasdaq Stockholm.

November 30, 2017

·

2 min read

BioMidwest

RSNA Release: Smartphone Addiction Creates Imbalance in Brain

Researchers have found an imbalance in the brain chemistry of young people addicted to smartphones and the internet, according to a study presented today at the annual meeting of the RSNA.

November 30, 2017

·

3 min read

Sinovac Biotech Announces Update on Nasdaq Matters

Sinovac announced today that the Nasdaq Hearings Panel granted the Company’s request to extend the stay of suspension in trading of the Company’s common shares pending a hearing on January 11, 2018 and issuance of a final Panel decision.

November 30, 2017

·

2 min read

Counsyl Celebrates Anniversary With $80M F

Genetown

Boston’s Anti-Aging Startup resTORbio Scores $40M

This financing brings the total capital raised this year to $65 million, including a $25 million Series A financing that was completed earlier this year.

November 30, 2017

·

4 min read